Promising clinical data for TS-23 supports future development in thrombotic vascular diseases Nov. 17, 2016 No Comments
Modus Therapeutics gives update on phase II sevuparin study in sickle cell disease Nov. 16, 2016 No Comments
Sanofi Genzyme opts in to expand rights to codevelop, co-commercialize Alnylam's fitusiran Nov. 15, 2016 No Comments
Combining Cas9 RNP with ssODN mediates efficient HSPC genome editing of sickle mutation Nov. 14, 2016 No Comments
Prometic Life Sciences reports positive data in phase II/III trial of IV plasminogen Oct. 28, 2016 No Comments
RSS